Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Classificação em ações #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Preço da ação
$1.30
Última sincronização: 2023-10-13
Valor de mercado
$38.02M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Zynerba Pharmaceuticals, Inc. (ZYNE)

Categoria

Histórico de preços das ações de Zynerba Pharmaceuticals, Inc. (ZYNE)
Preço de fecho mais alto: $1.27 em 2023-10-01

Preço de fecho mais baixo: $28.18 em 2015-08-01
Histórico de preços das ações da Zynerba Pharmaceuticals, Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$162.44 24.86%
DE
$38.00 22.72%
JP
$221.55 33.82%
CH
$21.01 11.96%
IN